Glioblastoma's antigenic heterogeneity and immunosuppressive microenvironment limit therapeutic efficacy. In this issue, Zhang et al. present a multimodal platform where engineered probiotics "paint" diverse tumor cells with a common tag, enabling universal... ...

请注册登录后继续浏览